Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
10719 | 973 | 25.6 | 72% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
2612 | 3094 | CYTOMETRY//CYTOMETRY PART A//LASER SCANNING CYTOMETRY |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | SINGLE PLATFORM | Author keyword | 18 | 65% | 2% | 17 |
2 | CD4 TESTING | Author keyword | 17 | 100% | 1% | 8 |
3 | TOTAL LYMPHOCYTE COUNT | Author keyword | 15 | 56% | 2% | 18 |
4 | HIV MONITORING | Author keyword | 10 | 63% | 1% | 10 |
5 | UK NEQAS LEUCOCYTE IMMUNOPHENOTYPING | Address | 9 | 55% | 1% | 12 |
6 | CYTOMETRY PART B-CLINICAL CYTOMETRY | Journal | 9 | 12% | 8% | 73 |
7 | DUAL PLATFORM | Author keyword | 8 | 75% | 1% | 6 |
8 | CD4 T CELL ENUMERATION | Author keyword | 8 | 100% | 1% | 5 |
9 | PANLEUCOGATING | Author keyword | 6 | 80% | 0% | 4 |
10 | LYMPHOCYTE IMMUNOPHENOTYPING | Author keyword | 5 | 50% | 1% | 7 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | SINGLE PLATFORM | 18 | 65% | 2% | 17 | Search SINGLE+PLATFORM | Search SINGLE+PLATFORM |
2 | CD4 TESTING | 17 | 100% | 1% | 8 | Search CD4+TESTING | Search CD4+TESTING |
3 | TOTAL LYMPHOCYTE COUNT | 15 | 56% | 2% | 18 | Search TOTAL+LYMPHOCYTE+COUNT | Search TOTAL+LYMPHOCYTE+COUNT |
4 | HIV MONITORING | 10 | 63% | 1% | 10 | Search HIV+MONITORING | Search HIV+MONITORING |
5 | DUAL PLATFORM | 8 | 75% | 1% | 6 | Search DUAL+PLATFORM | Search DUAL+PLATFORM |
6 | CD4 T CELL ENUMERATION | 8 | 100% | 1% | 5 | Search CD4+T+CELL+ENUMERATION | Search CD4+T+CELL+ENUMERATION |
7 | PANLEUCOGATING | 6 | 80% | 0% | 4 | Search PANLEUCOGATING | Search PANLEUCOGATING |
8 | LYMPHOCYTE IMMUNOPHENOTYPING | 5 | 50% | 1% | 7 | Search LYMPHOCYTE+IMMUNOPHENOTYPING | Search LYMPHOCYTE+IMMUNOPHENOTYPING |
9 | QUANTIBRITE | 4 | 75% | 0% | 3 | Search QUANTIBRITE | Search QUANTIBRITE |
10 | MESF | 4 | 36% | 1% | 9 | Search MESF | Search MESF |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ABSOLUTE CD4 | 30 | 100% | 1% | 12 |
2 | PLATFORM IMAGE CYTOMETER | 27 | 92% | 1% | 11 |
3 | FACSCOUNT SYSTEM | 20 | 100% | 1% | 9 |
4 | T CELL ENUMERATION | 15 | 82% | 1% | 9 |
5 | SINGLE PLATFORM | 15 | 54% | 2% | 19 |
6 | FICOLL HYPAQUE SEPARATION | 14 | 65% | 1% | 13 |
7 | MONOCLONAL ANTIBODY REAGENTS | 14 | 100% | 1% | 7 |
8 | ANTIBODY BINDING CAPACITY | 8 | 75% | 1% | 6 |
9 | PLATFORM FLOW CYTOMETRY | 8 | 100% | 1% | 5 |
10 | TRAX CD4 | 8 | 100% | 1% | 5 |
Journals |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CYTOMETRY PART B-CLINICAL CYTOMETRY | 9 | 12% | 8% | 73 |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
Emerging technologies for point-of-care CD4 T-lymphocyte counting | 2012 | 35 | 50 | 50% |
The Immunology Quality Assessment Proficiency Testing Program for CD3(+)4(+) and CD3(+)8(+) lymphocyte subsets: A ten year review via longitudinal mixed effects modeling | 2014 | 4 | 6 | 83% |
Emerging Technologies for Point-of-Care Management of HIV Infection | 2015 | 2 | 85 | 24% |
Evaluation of a flow cytometry method for CD4 T cell enumeration based on volumetric primary CD4 gating using thermoresistant reagents | 2011 | 10 | 25 | 88% |
CD4 counting technologies for HIV therapy monitoring in resource-poor settings - state-of-the-art and emerging microtechnologies | 2013 | 9 | 78 | 51% |
Immune status monitoring of HIV/AIDS patients in resource-limited settings: a review with an emphasis on CD4(+) T-lymphocyte determination | 2012 | 6 | 54 | 93% |
Evaluating new CD4 enumeration technologies for resource-constrained countries | 2008 | 9 | 45 | 80% |
A review on peripheral blood CD4+T lymphocyte counts in healthy adult Indians | 2010 | 9 | 67 | 66% |
CD4+T cell count as a tool to monitor HIV progression & anti-retroviral therapy | 2005 | 14 | 27 | 89% |
Low-cost assays for monitoring HIV infected individuals in resource-limited settings | 2011 | 11 | 75 | 43% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | UK NEQAS LEUCOCYTE IMMUNOPHENOTYPING | 9 | 55% | 1.2% | 12 |
2 | DEMIRCI BIOACOUST MEMS MED BAMM | 3 | 42% | 0.5% | 5 |
3 | EXCELLENCE FLOW CYTOMETRY | 3 | 42% | 0.5% | 5 |
4 | HIV IMMUNOL | 2 | 22% | 1.0% | 10 |
5 | BIOMED ENGN MEDDEMIRCI BIOACOUST MEMS M | 2 | 67% | 0.2% | 2 |
6 | FIELD EPIDEMIOL TRAINING | 2 | 67% | 0.2% | 2 |
7 | OFF DEV EXCELLENCE FLOW CYTOMETRY | 1 | 31% | 0.4% | 4 |
8 | TRANSPLANT IMMUNOL HEMATOL | 1 | 38% | 0.3% | 3 |
9 | BIOACOUST MEMS MED BAMM BIOMED ENGN | 1 | 50% | 0.2% | 2 |
10 | CELLULAR TISSUE THER Y BRANCHOFF CELLULAR TIS | 1 | 100% | 0.2% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000176886 | MASS CYTOMETRY//CYTOMETRY PART A//CYTOF |
2 | 0.0000163564 | INTEGRIN BETA 2//INTERNAL EMERGENCY//BIO OURCES ECT |
3 | 0.0000127198 | NEONATAL T CELLS//FETAL IMMUNOLOGY//GASTROENTEROL PAEDIAT NUTR SERV |
4 | 0.0000094657 | HIV INCUBATION DISTRIBUTION//REPORTING DELAY//NONPROGRESSORS |
5 | 0.0000080125 | LOSS TO FOLLOW UP//KNOWLEDGE TRANSLAT UNIT//HLTH ECON EPIDEMIOL OFF |
6 | 0.0000080059 | CALIPER PROGRAM//REFERENCE INTERVALS//REFERENCE INDIVIDUAL |
7 | 0.0000074825 | HEMATOGONES//BIPHENOTYPIC ACUTE LEUKEMIA//IMMUNOPHENOTYPING |
8 | 0.0000072252 | IMMUNE RECONSTITUTION//CLIN MOL RETROVIROL SECT//IMMUNE ACTIVATION |
9 | 0.0000072142 | IDIOPATHIC CD4 T LYMPHOCYTOPENIA//IDIOPATHIC CD4 LYMPHOCYTOPENIA//CD4 LYMPHOCYTOPENIA |
10 | 0.0000071668 | DOUBLE POSITIVE T CELLS//CD4CD8 T CELLS//CD8 INFECTION |